Dr Claire Shepherd in the Sydney Brain Bank labs

Sydney Brain Bank



What do we do?

Our aim is to provide Australian and international researchers with access to well characterised post-mortem human central nervous system tissue through an integrated process.

The objective of the Sydney Brain Bank is to collect, characterise and distribute human brain (and spinal cord) tissue for research purposes. We seek to facilitate meaningful research into neurodegenerative conditions to enable better treatments, quicker and more accurate diagnoses, and ultimately development of preventions and cures.

Our primary focus is on the collection of cases with neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, motor neuron disease, Huntington’s disease and frontotemporal lobar degeneration. Unaffected or “control” cases are also collected to act as comparators for disease but also to enable studies on healthy ageing.


Why is having a brain bank so important?

Neurodegenerative disorders have a huge personal and social impact in addition to an ever-increasing economic burden to individuals and the community. There are currently no treatments that target disease, rather only treatments that may offer some temporary relief from symptoms.

Current imaging techniques still cannot assess many cellular biological aspects of the brain, particularly at the molecular level. This is the level that is primarily affected in neurodegenerative diseases, and is the level required to definitively diagnose these diseases and to understand their cellular causes. This is why such tissue and the Sydney Brain Bank is needed for research into understanding and curing these disorders.

Researchers in Australia and overseas interested in investigating areas such as basic disease mechanisms, earlier and more accurate diagnosis, genetic contributions to diseases, better treatments, and ultimately, cure and prevention, can request this tissue for their research studies.


Who funds and supports the Sydney Brain Bank?

To be successful in these goals and endeavours, we rely on the generosity and altruism of people who participate in longitudinal brain donor programs during life and who choose to donate their brains for research after death. We also depend on scientists who request the tissue seeking to alleviate the suffering that neurodegenerative diseases cause.

The Sydney Brain Bank is cooperatively managed and supported by NeuRA and the Faculty of Medicine, University of New South Wales.

NeuRA logoUNSW logo

Who is involved in running the Sydney Brain Bank?

The Sydney Brain Bank is governed by a management committee, is directed by Dr Claire Shepherd and managed by Heather McCann. The Brain Bank operates with the NSW Brain Tissue Resource Centre at The University of Sydney as the NSW Brain Banks (NSWBB).

Sydney Brain Bank staff members:

Dr Claire Shepherd (Director)
Professor Glenda Halliday (Research Neuropathologist)

Heather McCann (Manager)

Francine Carew-Jones (Brain donor liaison officer)

Andrew Affleck (Research associate)

Adèle Lusson (Research assistant)

Carla Scicluna (Research assistant)


Want to learn more about the Sydney Brain Bank and brain donation? Then please head to our Frequently Asked Questions page


The Sydney Brain Bank is based at Neuroscience Research Australia (NeuRA) which is located next to the Prince of Wales Hospital on Barker St in Randwick NSW.

Find us on Google maps
Download a Randwick Hospitals campus map (PDF)



See what’s going on at NeuRA


Ten siblings. One third live (or have passed away) with dementia.

The scourge of dementia runs deep in Lorna Clement's family. Of the eleven children her dear parents raised, four live (or have passed away) with complications of the disease. Her mother also died of Alzheimer's disease, bringing the family total to five. This is the mystery of dementia - One family, with two very different ageing outcomes. You will have read that lifestyle is an important factor in reducing the risk of dementia. We also know diet is a key factor, and an aspect that Dr Ruth Peter's is exploring at NeuRA. Along with leading teams delivering high profile evidence synthesis work in the area of dementia risk reduction, Dr Peters has a particular interest in hypertension (that is, high blood pressure) and in the treatment of hypertension in older adults. “We have known for a while that treating high blood pressure reduces the risk of cardiovascular disease and stroke, but it is becoming clearer that controlling blood pressure may also help to reduce the risk of cognitive decline and dementia. Now we need to know what the best blood pressure is to protect brain health.” You are invited to read more about Lorna's story and Dr Peter's work, by clicking 'Read the full story' below. Please support dementia research at NeuRA Will you consider a gift today to help Dr Peter's unlock the secrets of healthy ageing and reduce the risk of dementia? Research into ageing and dementia at NeuRA will arm doctors and other medical professionals with the tools they need to help prevent dementia in our communities. Thank you for your support.